BackVincerx Pharma Overview

Vincerx Pharma Research & Development

Research & Development expenses for VINC.

Quarterly R&D Expenses

$1.02M
↓ 76.28% YoY

As of Mar 31, 2025

Annual R&D Expenses (TTM)

$11.95M
↓ 46.71% YoY

Trailing 12 months ending Mar 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin